热撕脱作为内镜下黏膜切除术辅助手段的安全性与有效性(附视频)
该研究回顾性分析了2015至2017年间564例连续转诊结肠息肉的内镜下黏膜切除术(EMR),在圈套器切除失败时使用热撕脱。热撕脱用于20.9%(n=112)的病变,随访结肠镜复发率热撕脱组为17.52%,非热撕脱组为16.02%(P=.76);热撕脱与迟发出血(5.35% vs 2.58%;P=.15)和凝固后综合征(1.8% vs 0.47%;P=.15)发生率升高趋势相关,但接受任何撕脱的息肉比未使用撕脱的息肉更大(P<.001)。结论认为,与既往使用氩离子凝固术处理可见息肉的报道不同,对可见/纤维化肿瘤行热撕脱的EMR疗效与无需热撕脱的病例相似,安全性似乎可接受。
要点
- 热撕脱用于20.9%(n=112)的结肠EMR病变,随访复发率17.52% vs 16.02%(P=.76)。
- 热撕脱组迟发出血5.35% vs 2.58%(P=.15),凝固后综合征1.8% vs 0.47%(P=.15)。
- 接受任何撕脱的息肉比未使用撕脱的息肉更大(P<.001)。
核心结论
- 对可见/纤维化肿瘤行热撕脱的EMR疗效与无需热撕脱的病例相似,安全性似乎可接受。
研究设计与样本
- 回顾性分析2015至2017年间564例连续转诊结肠息肉的内镜下黏膜切除术(EMR),圈套器切除失败时使用热撕脱,比较使用与未使用热撕脱的息肉。
主要发现
- 热撕脱用于20.9%(n=112)的切除病变。
- 随访结肠镜复发率热撕脱组17.52% vs 非热撕脱组16.02%(P=.76)。
- 热撕脱与迟发出血升高趋势相关(5.35% vs 2.58%;P=.15)。
- 热撕脱与凝固后综合征升高趋势相关(1.8% vs 0.47%;P=.15)。
- 接受任何撕脱的息肉比未使用撕脱的息肉更大(P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 不良事件数量不足,无法进行多变量分析以检验撕脱、大小和位置对总体不良事件风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Excision of all visible neoplastic tissue is the goal of EMR of colorectal laterally spreading tumors. Flat and fibrotic tissue can resist snaring. Ablation of visible polyps is associated with high recurrence rates. Avulsion is a technique to continue resection when snaring fails. METHODS: We retrospectively analyzed colonic EMRs of 564 consecutive referred polyps between 2015 and 2017. Hot avulsion was used when snaring was unsuccessful. Polyps treated with and without avulsion were compared. RESULTS: Hot avulsion was used in 20.9% (n = 112) of all resected lesions. The recurrence rates on follow-up colonoscopy were 17.52% in the avulsion group versus 16.02% in the non-avulsion group (P = .76). Hot avulsion was associated with a trend toward higher rates of delayed hemorrhage (5.35% vs 2.58%; P = .15) and post-coagulation syndrome (1.8% vs 0.47%; P = .15), but polyps treated with any avulsion were larger than those in which no avulsion was used (P < .001). There were an insufficient number of adverse events to perform a multivariable analysis to test the effects of avulsion, size, and location on the risk of overall adverse events. CONCLUSIONS: Unlike previous reports of using argon plasma coagulation to treat visible polyps during EMR, hot avulsion of visible/fibrotic neoplasia was associated with similar EMR efficacy compared with cases that did not require hot avulsion. The safety profile of hot avulsion appears acceptable.
引用
- Kumar V, Broadley H, Rex DK, et al. Safety and efficacy of hot avulsion as an adjunct to EMR (with videos). Gastrointest Endosc. 2018. PMID: 30529357. doi:10.1016/j.gie.2018.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。